• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight.托芬那酸-壳聚糖分子间相互作用的研究:pH 值、聚合物浓度和分子量的影响。
AAPS PharmSciTech. 2013 Jun;14(2):870-9. doi: 10.1208/s12249-013-9974-9. Epub 2013 Apr 27.
2
Effect of pH, polymer concentration and molecular weight on the physical state properties of tolfenamic acid.pH值、聚合物浓度和分子量对托芬那酸物理状态性质的影响。
Pharm Dev Technol. 2015 May;20(3):352-60. doi: 10.3109/10837450.2013.871027. Epub 2014 Jan 13.
3
Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide.基于壳聚糖和聚乙烯吡咯烷酮互穿网络的水凝胶用于瑞格列奈的pH敏感递送。
Curr Drug Discov Technol. 2011 Jun;8(2):126-35. doi: 10.2174/157016311795563848.
4
Influence of chitosan and carboxymethylchitosan on the polymorphism and solubilisation of diflunisal.壳聚糖和羧甲基壳聚糖对双氯芬酸钠多晶型和溶解性能的影响。
Int J Pharm. 2014 Jun 5;467(1-2):19-26. doi: 10.1016/j.ijpharm.2014.03.041. Epub 2014 Mar 24.
5
Development and characterization of novel polyurethane films impregnated with tolfenamic acid for therapeutic applications.新型载甲苯磺酸氨丁三醇聚氨酯薄膜的研制及性能表征。
Biomed Res Int. 2013;2013:178973. doi: 10.1155/2013/178973. Epub 2013 Sep 1.
6
Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.采用机械化学活化法制备替米沙坦-壳聚糖固体分散体的溶解性能及物理特性研究。
AAPS PharmSciTech. 2013 Jun;14(2):541-50. doi: 10.1208/s12249-013-9937-1. Epub 2013 Feb 21.
7
Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.抗组胺药物的单宁酸盐配合物:缓释和掩味方法。
Int J Pharm. 2012 Jan 17;422(1-2):91-100. doi: 10.1016/j.ijpharm.2011.10.033. Epub 2011 Oct 21.
8
Characterization and physical stability of tolfenamic acid-PVP K30 solid dispersions.托芬那酸-PVP K30固体分散体的表征及物理稳定性
Pharm Dev Technol. 2007;12(1):43-53. doi: 10.1080/10837450601166577.
9
Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.曲尼司特无定形固体分散体的理化性质和药代动力学特征研究:提高了在胃液中的溶解度和口服生物利用度。
Drug Metab Pharmacokinet. 2012;27(4):379-87. doi: 10.2133/dmpk.dmpk-11-rg-101. Epub 2012 Jan 13.
10
Binding of sulfamethazine to β-cyclodextrin and methyl-β-cyclodextrin.磺胺甲噁唑与β-环糊精和甲基-β-环糊精的结合。
AAPS PharmSciTech. 2013 Jun;14(2):727-35. doi: 10.1208/s12249-013-9958-9. Epub 2013 Apr 19.

引用本文的文献

1
Photolysis of tolfenamic acid in aqueous and organic solvents: a kinetic study.托芬那酸在水性和有机溶剂中的光解:一项动力学研究。
RSC Adv. 2024 Jul 8;14(30):21383-21397. doi: 10.1039/d4ra01369g. eCollection 2024 Jul 5.
2
Analysis of Tolfenamic Acid using a Simple, Rapid, and Stability-indicating Validated HPLC Method.采用简单、快速、稳定指示的 HPLC 法分析托芬那酸。
Antiinflamm Antiallergy Agents Med Chem. 2024;23(1):52-70. doi: 10.2174/1871523022666230608094152.
3
Preparation, Characterization and Pharmacokinetics of Tolfenamic Acid-Loaded Solid Lipid Nanoparticles.托芬那酸固体脂质纳米粒的制备、表征及药代动力学
Pharmaceutics. 2022 Sep 13;14(9):1929. doi: 10.3390/pharmaceutics14091929.
4
Polyelectrolyte Multilayer Films as a Potential Buccal Platform for Drug Delivery.聚电解质多层膜作为一种潜在的口腔给药平台。
Polymers (Basel). 2022 Feb 14;14(4):734. doi: 10.3390/polym14040734.
5
The Effect of Cross-linking Efficiency of Drug-Loaded Novel Freeze Gelated Chitosan Templates for Periodontal Tissue Regeneration.载药新型冷冻凝胶化壳聚糖模板交联效率对牙周组织再生的影响。
AAPS PharmSciTech. 2020 Jun 16;21(5):173. doi: 10.1208/s12249-020-01708-x.
6
Biomedical applications of polyelectrolyte coated spherical gold nanoparticles.聚电解质包覆的球形金纳米粒子的生物医学应用
Nano Converg. 2019 Apr 24;6(1):11. doi: 10.1186/s40580-019-0183-4.
7
Validation of a UV Spectrometric Method for the Assay of Tolfenamic Acid in Organic Solvents.用于测定有机溶剂中托芬那酸的紫外光谱法的验证
J Pharm (Cairo). 2015;2015:216249. doi: 10.1155/2015/216249. Epub 2015 Dec 10.
8
Development and characterization of novel polyurethane films impregnated with tolfenamic acid for therapeutic applications.新型载甲苯磺酸氨丁三醇聚氨酯薄膜的研制及性能表征。
Biomed Res Int. 2013;2013:178973. doi: 10.1155/2013/178973. Epub 2013 Sep 1.

本文引用的文献

1
Raman and IR spectroscopic studies of fenamates--conformational differences in polymorphs of flufenamic acid, mefenamic acid and tolfenamic acid.拉曼和红外光谱研究芳基烷酸——氟芬那酸、甲芬那酸和托芬那酸多晶型物的构象差异。
Spectrochim Acta A Mol Biomol Spectrosc. 2012 Oct;96:972-85. doi: 10.1016/j.saa.2012.07.129. Epub 2012 Aug 10.
2
Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression.托芬那酸诱导头颈部癌症细胞凋亡和生长抑制:NAG-1 表达的参与。
PLoS One. 2012;7(4):e34988. doi: 10.1371/journal.pone.0034988. Epub 2012 Apr 19.
3
Physicochemical investigations and stability studies of amorphous gliclazide.无定形格列齐特的物理化学研究及稳定性研究。
AAPS PharmSciTech. 2012 Jun;13(2):448-59. doi: 10.1208/s12249-012-9760-0. Epub 2012 Mar 2.
4
Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.托芬那酸抑制神经母细胞瘤细胞增殖并诱导细胞凋亡:一种用于神经母细胞瘤的新型治疗药物。
Mol Carcinog. 2013 May;52(5):377-86. doi: 10.1002/mc.21866. Epub 2011 Dec 28.
5
The ability of tolfenamic acid to penetrate the brain: a model for testing the brain disposition of candidate Alzheimer's drugs using multiple platforms.托芬那酸穿透血脑屏障的能力:使用多种平台测试候选阿尔茨海默病药物脑分布的模型。
Curr Alzheimer Res. 2011 Dec;8(8):860-7. doi: 10.2174/156720511798192691.
6
Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway.托芬那酸通过转录途径中断β-淀粉样前体蛋白的从头合成并降低淀粉样β。
Curr Alzheimer Res. 2011 Jun;8(4):385-92. doi: 10.2174/156720511795745285.
7
Chemopreventive effect of tolfenamic acid on KB human cervical cancer cells and tumor xenograft by downregulating specificity protein 1.托芬那酸通过下调特异性蛋白 1 对 KB 人宫颈癌细胞及肿瘤移植瘤的化学预防作用。
Eur J Cancer Prev. 2011 Mar;20(2):102-11. doi: 10.1097/CEJ.0b013e328341e38f.
8
Apoptotic Effect of Tolfenamic Acid in KB Human Oral Cancer Cells: Possible Involvement of the p38 MAPK Pathway.托芬那酸对 KB 人口腔癌细胞的凋亡作用:可能涉及 p38 MAPK 通路。
J Clin Biochem Nutr. 2010 Jul;47(1):74-80. doi: 10.3164/jcbn.10-02. Epub 2010 Jun 17.
9
A classification system to assess the crystallization tendency of organic molecules from undercooled melts.一种评估有机分子从过冷熔体中结晶倾向的分类系统。
J Pharm Sci. 2010 Sep;99(9):3787-806. doi: 10.1002/jps.22197.
10
Bismuth(III) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori.来源于非甾体抗炎药物的三价铋配合物及其抗幽门螺杆菌活性。
Dalton Trans. 2010 Mar 21;39(11):2861-8. doi: 10.1039/c000164c. Epub 2010 Feb 5.

托芬那酸-壳聚糖分子间相互作用的研究:pH 值、聚合物浓度和分子量的影响。

Studies on tolfenamic acid-chitosan intermolecular interactions: effect of pH, polymer concentration and molecular weight.

机构信息

Department of Materials Science and Engineering, The Kroto Research Institute, University of Sheffield, North Campus, Broad Lane, Sheffield, S3 7HQ, UK.

出版信息

AAPS PharmSciTech. 2013 Jun;14(2):870-9. doi: 10.1208/s12249-013-9974-9. Epub 2013 Apr 27.

DOI:10.1208/s12249-013-9974-9
PMID:23620261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3665981/
Abstract

Solid-state properties of tolfenamic acid (TA) and its complexes with chitosan (CT) have been studied. Effect of medium pH, molecular weight of polymer and its different concentrations on these TA-CT complexes were studied in detail. Low and medium molecular weight CT have been used in different ratios at pH ranging from 4 to 6 and freeze-drying technique has been employed to modify the appearance of crystalline TA. Physical properties of the formed complexes have been studied by employing X-ray diffraction, differential scanning calorimetry and scanning electron microscopy; chemical structure has been studied using Fourier transform infrared spectroscopy. The results showed that both forms of the polymer exhibited complete conversion in 1:8 ratio at pH 4, 1:4 at pH 5 and 1:1 at pH 6 indicating a marked effect of pH on drug-polymer complexation. The percent crystallinity calculations indicated low molecular weight CT slightly more effective than the other form. No changes in the complexes have been observed during the 12 week storage under controlled conditions. Both forms of CT at different pH values indicated retardation of recrystallization in TA during cooling of the melt from 1:1 ratios exhibiting formation of strong intermolecular hydrogen bonding between the drug and the polymer.

摘要

已研究了托芬那酸(TA)及其与壳聚糖(CT)复合物的固态性质。详细研究了介质 pH 值、聚合物分子量及其不同浓度对这些 TA-CT 复合物的影响。在 pH 值为 4 至 6 范围内,使用了不同比例的低分子量和中等分子量 CT,并采用冷冻干燥技术来改变结晶 TA 的外观。通过 X 射线衍射、差示扫描量热法和扫描电子显微镜研究了形成的复合物的物理性质;使用傅里叶变换红外光谱研究了化学结构。结果表明,在 pH 值为 4 时,两种形式的聚合物在 1:8 的比例下完全转化,在 pH 值为 5 时为 1:4,在 pH 值为 6 时为 1:1,表明 pH 值对药物-聚合物络合有明显影响。结晶度计算表明,低分子量 CT 比另一种形式稍微有效。在控制条件下储存 12 周期间,复合物没有发生变化。在冷却熔融物从 1:1 比例时,两种形式的 CT 在不同 pH 值下均表明 TA 中再结晶的延迟,表现为药物和聚合物之间形成强的分子间氢键。